You are here

Xenleta

Nabriva hit with another FDA setback with complete response letter for antibiotic Contepo

Fierce Pharma

Mon, 06/22/20 - 10:45 am

Nabriva Therapeutics

Nabriva gets first approval in novel antibiotic class

BioCentury

Mon, 08/19/19 - 11:34 pm

community-acquired bacterial pneumonia